Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Dogliotti

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Urology|February 26, 1999
Changes in free and free-to-total prostate specific antigen after androgen deprivation or chemotherapy in patients with advanced prostate cancerA Berruti, L Dogliotti, G Fasolis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Melatonin and human cancerL Dogliotti, A Berruti, T Buniva, et al.
Journal of Clinical Epidemiology|July 1, 1995
Wolfe's mammographic patterns in women with gross cystic disease of the breastL Bucchi, M Costantini, G Buzzi, et al.
BMJ (Clinical Research Ed.)|March 29, 1997
Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breastP Bruzzi, L Dogliotti, C Naldoni, et al.
Calcified Tissue International|November 14, 1997
Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone diseaseA Piovesan, A Berruti, M Torta, et al.
Cancer|June 22, 2000
Circulating neuroendocrine markers in patients with prostate carcinomaA Berruti, L Dogliotti, A Mosca, et al.
The Journal of Urology|September 19, 2000
Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baselineA Berruti, L Dogliotti, R Bitossi, et al.
Minerva Chirurgica|August 15, 1980
[Cytostatic therapy of metastatic breast cancer]A Mussa, L Dogliotti, S V Musumeci, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patientsS Bretti, A Berruti, G Gorzegno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinomaM P Brizzi, C M Sculli, F Ragni, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Urology|February 26, 1999
Changes in free and free-to-total prostate specific antigen after androgen deprivation or chemotherapy in patients with advanced prostate cancerA Berruti, L Dogliotti, G Fasolis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Melatonin and human cancerL Dogliotti, A Berruti, T Buniva, et al.
Journal of Clinical Epidemiology|July 1, 1995
Wolfe's mammographic patterns in women with gross cystic disease of the breastL Bucchi, M Costantini, G Buzzi, et al.
BMJ (Clinical Research Ed.)|March 29, 1997
Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breastP Bruzzi, L Dogliotti, C Naldoni, et al.
Calcified Tissue International|November 14, 1997
Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone diseaseA Piovesan, A Berruti, M Torta, et al.
Cancer|June 22, 2000
Circulating neuroendocrine markers in patients with prostate carcinomaA Berruti, L Dogliotti, A Mosca, et al.
The Journal of Urology|September 19, 2000
Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baselineA Berruti, L Dogliotti, R Bitossi, et al.
Minerva Chirurgica|August 15, 1980
[Cytostatic therapy of metastatic breast cancer]A Mussa, L Dogliotti, S V Musumeci, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patientsS Bretti, A Berruti, G Gorzegno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinomaM P Brizzi, C M Sculli, F Ragni, et al.
Pageof 15